"We're not waiting for the future of healthcare, we're building it. The future of personalized care starts here." ATLANTA, April 3, 2025 /PRNewswire/ -- OrderlyMeds, a vertically-integrated healthtech ...

OrderlyMeds has partnered with leading health and fitness-focused Meal Delivery Service Trifecta to provide GLP-1 Friendly meals for OrderlyMeds GLP-1 program members. SACRAMENTO, CA / ACCESSWIRE / ...

ATLANTA, April 11, 2025 /PRNewswire/ -- On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response.

One in eight Americans has taken a GLP-1 medication, according to a KFF Health Tracking poll. Formally known as glucagon-like peptide-1, GLP-1s are injectable prescription drugs that can be used to ...

ATLANTA, Jan. 30, 2024 /PRNewswire/ -- OrderlyMeds, a pioneering leader in healthcare solutions, is proud to announce the launch of its groundbreaking weight-loss management program in Atlanta, ...

OrderlyMeds is intentionally charting a different path from traditional, one-size-fits-all healthcare. While Big Pharma continues to prioritize mass production and standardized treatments, OrderlyMeds ...

The MarketWatch News Department was not involved in the creation of this content. OrderlyMeds has partnered with leading health and fitness-focused Meal Delivery Service Trifecta to provide GLP-1 ...